EVOK

Evoke Pharma Reports Second Quarter 2021 Financial Results

Evoke Pharma and EVERSANA Announce Support of The International Foundation for Gastrointestinal Disorders' (IFFGD) August Gastroparesis Awareness Month

Evoke Pharma Launches Gimoti® Patient and Physician Experience Program

Evoke Pharma, EVERSANA and The International Foundation for Gastrointestinal Disorders Announce Membership into IFFGD's Industry Council

Evoke Pharma and EVERSANA Announce Positive Findings from Second GIMOTI® Market Research Study

Evoke Pharma Announces FDA Orange Book Listing of U.S. Patent for Gimoti®